SoCal Maker Of Botox To Pay $600 Million After It Allegedly Lied About What It Can Be Used For
Botox might make you look strangely plump, like a cadaver that's received a full-on makeover at the mortuary, but it does not cure cerebral palsy, ease headaches, relieve pain, or soften muscle stiffness. Apparently.
That's according to a settlement the Southern California maker of Botox agreed to this week. The deal calls for Irvine-based Allergan to plead guilty to one misdemeanor count of misbranding its product. The company would also pay $600 million to resolve a federal investigation of its Botox claims, including $225 million in civil fines.
The company still denies liability for any civil claims related to the marketing probe.
Douglas S. Ingram, Allergan's executive vice president, stated that the deal "resolves all matters at issue in the investigation, avoids substantial costs of litigation, as well as the substantial risks to Allergan associated with government enforcement action in these matters, and permits us to focus our time and resources on productively developing new treatments for patients and the medical community.''
We have one for you. Bootietox. There could be a market for it.
Get the This Week's Top Stories Newsletter
Every week we collect the latest news, music and arts stories — along with film and food reviews and the best things to do this week — so that you’ll never miss LA Weekly's biggest stories.
- Why Is L.A. Such a Sad Place for Valentine's Day?
- L.A.'s Top Tech Guru Is Preparing for the Bubble to Burst
- 7 New Czars We Should Hire Right Now to Whip L.A. Into Shape